Upstream Bio, Inc. - Common Stock (UPB)
6.1000
-0.2000 (-3.17%)
NASDAQ · Last Trade: Apr 4th, 8:21 PM EDT

Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise.
Via MarketBeat · November 6, 2024

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics market.
Via Benzinga · November 5, 2024

Via Benzinga · November 5, 2024

The Partners Group-backed KinderCare sold 24 million shares for $24 each this past Tuesday. Meanwhile, a new trio of biotech companies' shares came to market on Friday, as Upstream Bio, CeriBell, and Camp4 Therapeutics each made their public debut.
Via Talk Markets · October 13, 2024